ARNA

Arena Pharmaceuticals, Inc. News Headlines

$4.16
*  
0.11
2.58%
Get ARNA Alerts
*Delayed - data as of Sep. 19, 2014  -  Find a broker to begin trading ARNA now
Exchange: NASDAQ
Industry: Health Care
Community Rating:
 
 
Symbol List Views
FlashQuotes InfoQuotes
Stock Details
Summary Quote Real-Time Quote After Hours Quote Pre-market Quote Historical Quote Option Chain
CHARTS
Basic Chart Interactive Chart
COMPANY NEWS
Company Headlines Press Releases Market Stream
STOCK ANALYSIS
Analyst Research Guru Analysis Stock Report Competitors Stock Consultant Stock Comparison
FUNDAMENTALS
Call Transcripts Annual Report Income Statement Revenue/EPS SEC Filings Short Interest Dividend History
HOLDINGS
Ownership Summary Institutional Holdings Insiders
(SEC Form 4)
 Save stocks for next time
Viewing
Filtered By
Ordered By

3 Biotechs Investors Should Watch
9/19/2014 1:49:27 PM - Motley Fool

A Deeper Look At Belviq And Phentermine - Why Investors Need To Model Expectations
9/19/2014 12:08:00 PM - Seeking Alpha

Arena Pharmaceuticals, Inc. (ARNA) Jumps: Stock Rises 9.5% - Tale of the Tape
9/19/2014 9:11:00 AM - Zacks.com

It Takes Less Than 15 Minutes To Buy VVUS Shares!
9/19/2014 8:51:00 AM - Seeking Alpha

NASDAQ Biotech Top Performers (Pre-Open September 19)
9/19/2014 8:30:58 AM - David Krein

Why VIVUS, Inc. Is Today's Best Biotech Stock
9/18/2014 1:26:33 PM - Motley Fool

5 Things Arena Pharmaceuticals, Inc.'s Management Wants You to Know
9/17/2014 10:51:08 AM - Motley Fool

Belviq And Phentermine Study Awes Some Investors - Should It?
9/17/2014 10:00:00 AM - Seeking Alpha

Orexigen Therapeutics Wins Contrave Approval But Investors Should Stay Away
9/16/2014 2:01:00 PM - Seeking Alpha

Doc Offers Glimpse Into Arena Pharma Weight-Loss Combination Therapy
9/16/2014 9:48:00 AM - TheStreet

Orexigen Falls After Approval - Why?
9/15/2014 2:25:00 PM - Seeking Alpha

Arena And Vivus Ruined The FDA Approval Run Up For Orexigen
9/13/2014 8:02:00 PM - Seeking Alpha

2 New Diet Drugs Coming Soon?
9/13/2014 2:05:03 PM - Motley Fool

Novo Gets Positive Vote From FDA For Anti-Obesity Treatment - Still A Long Road Ahead
9/12/2014 5:18:00 PM - Seeking Alpha

Belviq Sales See Holiday Dip - Still On Track
9/12/2014 5:17:00 PM - Seeking Alpha

Orexigen: Poised To Grab A Large Part Of The Weight Loss Market
9/12/2014 1:40:00 PM - Seeking Alpha

Belviq Advertising Sees Major Shift
9/12/2014 1:22:00 PM - Seeking Alpha

Surprising New Competitor: Should Arena Pharmaceuticals, Inc. and Orexigen Therapeutics, Inc. Be Afr
9/12/2014 9:09:40 AM - Motley Fool

FDA Approves Orexigen Therapeutics Inc.'s Goldilocks Obesity Drug
9/11/2014 4:46:01 PM - Motley Fool

How Will Orexigen Therapeutics (OREX) Stock Respond to FDA's Contrave Approval?
9/11/2014 4:10:00 PM - TheStreet

Orexigen's Contrave Approved: What It Means To Arena
9/11/2014 10:02:00 AM - Seeking Alpha

FDA Approves Orexigen's Contrave For Obesity Treatment
9/11/2014 9:22:00 AM - Seeking Alpha

FDA Approves Orexigen's Diet Drug Contrave
9/11/2014 8:35:00 AM - Dow Jones Business News

Arena Pharmaceuticals - A Biotech Value Investment
9/10/2014 4:49:00 PM - Seeking Alpha

Why Arena Pharmaceuticals, Inc. Stock Crashed By 31% in 2014
9/9/2014 9:45:02 AM - Motley Fool